Page last updated: 2024-08-18

pyrroles and Autoimmune Lymphoproliferative Syndrome

pyrroles has been researched along with Autoimmune Lymphoproliferative Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hiroi, T; Kaminuma, O; Perera, LP; Perera, PY; Terawaki, S; Waldmann, TA; Watanabe, N; Yokoyama, S	1

Other Studies

1 other study(ies) available for pyrroles and Autoimmune Lymphoproliferative Syndrome

Article	Year
Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS). Journal of clinical immunology, 2015, Volume: 35, Issue:7 Topics: Animals; Autoimmune Lymphoproliferative Syndrome; Disease Models, Animal; fas Receptor; Humans; Immunoglobulins; Janus Kinase 3; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Mutation; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory	2015

Article

Year

Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS).

Journal of clinical immunology, 2015, Volume: 35, Issue:7

Topics: Animals; Autoimmune Lymphoproliferative Syndrome; Disease Models, Animal; fas Receptor; Humans; Immunoglobulins; Janus Kinase 3; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Mutation; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory

2015